Kumar, A. H. (2021) “Network Pharmacology Analysis of Orally Bioavailable SARS-CoV-2 Protease Inhibitor Shows Synergistic Targets to Improve Clinical Efficacy”, Biology, Engineering, Medicine and Science Reports, 7(2), pp. 21–24. doi: 10.5530/bems.7.2.8.